GRI Bio, Inc.
GRI · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Kelly Leanne: Form 4
Insider disclosure · Filed · Report period 18 Sep 2025
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001824293 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GRI on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2223 Avenida De La Playa, Suite 208, La Jolla, CA, 92037
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Vallon Pharmaceuticals, Inc. (to 21 Apr 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields